DRAP launches crackdown on fake drugs following provincial alarms
WEB DESK: The Drug Regulatory Authority of Pakistan (DRAP) has launched a nationwide crackdown on counterfeit and substandard pharmaceutical products after shocking health complaints from Khyber Pakhtunkhwa, Punjab, and Sindh giving rise to different batches of medicines and medical products described as counterfeit or substandard. DRAP now issues recalls for
DRAP launches advisory to combat antimicrobial resistance
DRAP issues advisory to combat antimicrobial resistance and self-medication. The Drug Regulatory Authority of Pakistan (DRAP) announced an advisory aimed at addressing the growing threat of Antimicrobial Resistance (AMR) and curbing the dangerous trend of self-medication. Moreover, DRAP Chief Executive Officer, Asim Rauf, highlighted that the misuse and overuse of
DRAP bans four harmful medicines including cough syrups
The Drug Regulatory Authority of Pakistan (DRAP) has banned the sale of certain batches of four medicines, including two cough syrups, after declaring them hazardous to health. This move follows findings from a drug testing laboratory report, which identified eight batches of two drugs and four batches of four additional